NEWS

NAFDAC Bans Sale, Use Of Dex Luxury Bar Soap

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert, declaring a ban on the sale and use of Dex Luxury Bar Soap.

This action was announced in a statement on the agency’s website, citing the presence of Butyphenyl Methylpropional (BMHCA) in the soap as the reason for the ban.

NAFDAC said, “The product does not comply with the Cosmetic Products Regulation as it is said to contain Butyphenyl Methylpropional (BMHCA) which is prohibited in cosmetic products due to its risk of harming the reproductive system, causing harm to the health of the unborn child and may cause skin sensitization.

“As a result, a ban on the marketing of the product has been placed by some regulatory and public authorities in the EU.”

The agency gave the product details as follows: Product Name – Dex Luxury Bar Soap (No 6 Mystic Flower); Product Brand – DEX; Country of Manufacture – Turkey; Model – 11.11.22; Barcode – 8694965531 and Category – Cosmetics.

The statement added, “Although these products are not in the NAFDAC database, importers, distributors, retailers, and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of the above-mentioned product.

“The product’s authenticity and physical condition should be carefully checked. Members of the public in possession of the product should discontinue the sale or use and submit stock to the nearest NAFDAC office.

“Healthcare professionals and consumers are advised to report any suspicion of adverse reactions, or substandard and falsified regulated products to the nearest NAFDAC office on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng.

“Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of the products to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med-safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng.”

………….

Note : To submit Press Releases, Statements, and Advert Inquiries for publication on Waffi blog (website) or Television 📺, please use the following contact details: You can send an email to info@waffitv.com or reach us via Whatsapp at 07068286500

Related posts

Student Loan Disbursement To Start By September- FG

Waffi Tv

FG Announces N25,000 Grant To Vulnerable Pensioners

Waffi Tv

By-Elections: PDP Releases Timetable, Pegs Senate Form At N3.5m

Waffi Tv

Leave a Comment